The journey to bring a new therapy to patients is one of the most challenging and impactful undertakings in our industry. It typically takes 10 to 12 years, with only about 7.9% of candidates making it through successfully. The financial investment can reach up to $1 billion, and delays in clinical trials or regulatory approval can amount to millions in losses. (View Source) There’s risk throughout the value chain, from discovery to clinical development to commercial scale-up. Failure rates are high, timelines are long, and capital is tighter than ever.
But these numbers tell only part of the story. Behind each statistic are real people. Hundreds of thousands of patients intently waiting for treatments that could change their lives. Every month of delay isn’t just a financial setback for an organization; it’s a life on hold, a hope deferred.
That’s why at Syner-G accelerating innovation isn’t just a goal for us, it’s a moral imperative. We are committed to helping our partners push the boundaries of what’s possible, because at the end of the day, it’s about making a meaningful difference in the lives of those who need it most.
A year ago, we realized that to do this successfully, our clients need more than siloed services, they need a true strategic partner. Someone who can help them see the big picture, act with agility, and execute seamlessly across every stage of development and commercialization. An ally who can adapt quickly, anticipate obstacles before they arise, and remain laser-focused on creating long-term value. That’s the commitment we’ve made, to be that partner, every step of the way.
That insight has shaped how we’ve evolved Syner-G. Today, I’m proud to introduce our new brand and service delivery model, designed to help biopharmaceutical innovators accelerate their science, reduce risk, and bring transformative therapies to patients faster.
A Strategic Development and Delivery Partner™
As a Strategic Development and Delivery Partner™, Syner-G helps biopharma companies de-risk and accelerate their path to approval. We bring together integrated scientific, regulatory, technical, and strategic consulting expertise across the development lifecycle, from preclinical to approval and beyond.
Our solutions are grounded in science, built to reduce risk, and designed to advance therapies efficiently through development and beyond approval.
Strategy as Dynamic as Science Itself
In biopharma innovation, progress rarely follows a straight line. Experiments surprise, data shifts, and strategies must adapt. The companies that thrive are those equipped to react and pivot without losing momentum.
At Syner-G, we help clients build that agility into their development model. When you engage with us, you’re not hiring a few consultants, you’re gaining access to a cohesive team of more than 400 scientific, regulatory, strategy, and technical experts who share insights, ask tough questions, and solve problems together.
That collective intelligence is our competitive advantage. We interact with the FDA every month across teams and programs, providing clients with current, practical guidance rooted in real-world experience. Whether your challenge is early-stage strategy, regulatory planning, or manufacturing execution, we have the depth and breadth to move your program forward with confidence.
Why “Buying Down Risk” Matters Now More Than Ever
In today’s environment, the ability to de-risk and accelerate is more than a competitive edge, it’s a survival skill. One misstep, one delay, one regulatory setback can easily set years of progress back and put everything at risk.
At Syner-G, we look at risk through multiple lenses:
- Science: We help you navigate the high-stakes journey of development with confidence, making science-led, informed decisions to prevent costly setbacks, accelerate approval timelines, and ensure therapies get to market safely and quickly.
- Strategy: We enable strategic transformation by aligning vision, people, processes, and technology, using agile, practical solutions to help you adapt, stay aligned, and create lasting impact.
- Delivery: We help you scale fast without cutting corners, accelerate manufacturing readiness and operational scale.
No matter your role, success depends on managing uncertainty and sustaining momentum… and that’s where we come in—to support you in achieving exactly that.
Focus on the Breakthroughs. We’ll Handle the Rest.
Your mission is to discover life-changing therapies, ours is to help you remove the complexity and reduce risk so you can accelerate your breakthrough science. With expanded capabilities in product development, regulatory strategy, manufacturing, and commercialization, we help you move faster and scale bigger.
Partnering with Syner-G isn’t just outsourcing — it’s about increasing your chances of success. We help turn uncertainty into clarity, molecules into approved therapies, and bold visions into reality. Together, we can ensure your breakthroughs reach the patients who need them most.
From science to success.
